D-0942-2017 Class III Terminated

Recalled by Lantheus MI Radipharmaceuticals Inc. — San Juan, PR

FDA drug recall D-0942-2017 was initiated by Lantheus MI Radipharmaceuticals Inc. on May 18, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent The recall status is terminated (terminated Dec 6, 2017). Affected quantity: 26 doses.

Recall details

Product Type
Drugs
Report Date
Jul 12, 2017
Initiation Date
May 18, 2017
Termination Date
Dec 6, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
26 doses

Product description

Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01

Reason for recall

Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

Distribution pattern

Puerto Rico

Code information

Lot: FDG170518-01, exp 5/18/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0942-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0942-2017. Report a data issue: hello@regdatalab.com.